Hormones

Subscribe to Selected New Research on Hormones

43760 relevant articles (1346 outcomes, 4821 trials/studies) found for this Bio-Agent

Description: Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.

Also Known As:

Hormone

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Small, Eric J: 26 articles (02/2008 - 06/2002)
2.	Vogelzang, Nicholas J: 19 articles (02/2008 - 02/2002)
3.	Halabi, Susan: 12 articles (02/2008 - 02/2002)
4.	Kantoff, Philip W: 11 articles (05/2008 - 04/2002)
5.	Colditz, Graham A: 11 articles (08/2007 - 07/2002)
6.	Oh, William K: 10 articles (05/2008 - 12/2003)
7.	Hankinson, Susan E: 10 articles (08/2007 - 07/2002)
8.	Brinton, Louise A: 10 articles (01/2008 - 10/2004)
9.	Akaza, Hideyuki: 9 articles (08/2007 - 11/2002)
10.	Chlebowski, Rowan T: 9 articles (11/2007 - 08/2002)

Related Diseases

1.	Neoplasms (Cancer) 07/01/2005 - "Our in vitro results show that salicylhydrazides are highly potent compounds effective in both hormone receptor-positive and -negative cancer cells" 11/01/2002 - "Whilst opinion remains divided on the best treatment for localized disease, intervention for metastatic, hormone-independent cancer remains extremely limited" 02/01/1984 - "PSN research has yielded best results through the examination of those hormones produced by the tumor, esp" 09/28/2008 - "Lactone moiety-containing molecules may form the structural basis for the development of potent drugs effective against hormone-dependent cancers." 01/01/1981 - "However, response rates related to previous therapy and to important prognostic variables such as age of the patient, disease-free interval and hormone receptor content of the tumor tissue are poorly elucidated" Get all the results and reference details, order at left...
2.	Prostatic Neoplasms (Prostate Cancer) 07/01/2008 - "Our understanding of the biology of hormone refractory prostate cancer has improved dramatically over the past few years and has translated into the developments of new therapeutic targets for this disease" 10/15/2006 - "Despite the initial efficacy of androgen deprivation therapy, most patients with advanced prostate cancer eventually progress to hormone-refractory prostate cancer, for which there is no curative therapy" 08/01/2006 - "There is no effective cure for late-stage hormone (androgen) refractory prostate cancer" 12/01/1984 - "In some clinical trials the use of criteria of stable response of hormone-escaped prostate cancer is justified on the ground that it delineates patients with markedly improved survival, similar to that of partial regression patients" 09/01/2008 - "A considerable proportion of men with clinically localized prostate cancer are not cured by surgery or radiotherapy, and hormone therapy for advanced disease is also not curative" Get all the results and reference details, order at left...
3.	Breast Neoplasms (Breast Cancer) 01/01/2007 - "Our data indicate that hCG, like pregnancy, induces permanent genomic changes that are not reproduced by steroid hormones and in addition regulates gene expression through epigenetic mechanisms that are differentiation-dependent processes, leading us to conclude that hormonally induced differentiation offers enormous promise for the primary prevention of breast cancer." 02/07/2004 - "We report the findings of the safety analysis in HABITS (hormonal replacement therapy after breast cancer--is it safe?), an open randomised clinical trial with allocation to either HRT or best treatment without hormones" 01/01/2003 - "The assessment of steroid hormone receptors in resected breast cancer tissues is essential to decide whether endocrine therapy is indicated and to select the best treatment for each patient on the basis of receptor status" 08/01/2002 - "Currently it is the most widely used agent for first line treatment against hormone sensitive metastatic breast cancer and the only approved hormonal agent for adjuvant treatment of organ confined breast cancer" 05/01/2004 - "Hormone receptor status has long been considered important in predicting the efficacy of endocrine agents for the treatment of breast cancer" Get all the results and reference details, order at left...
4.	Carcinoma (Carcinomatosis) 04/01/1982 - "The prognosis for breast carcinoma developing in hormone users is improved, most likely because of an earlier detection" 01/01/1994 - "The unavailability of effective treatment for metastatic hormone-refractory and clinically localized but pathologically unfavorable prostatic carcinoma warrants trial of new and promising treatments" 01/01/1992 - "The unavailability of effective treatment of metastatic hormone refractory prostatic carcinoma warrants trials of new and promising treatments" 01/01/2006 - "Long-term hormone therapy and radiation is cost-effective for patients with locally advanced prostate carcinoma." 02/01/2000 - "BACKGROUND: There is currently no effective treatment for recurrent hormone refractory carcinomas of the prostate gland" Get all the results and reference details, order at left...
5.	Syndrome 01/01/1980 - "A high therapeutic efficacy of the hormones in the treatment of amnestic syndromes is demonstrated." 01/01/1990 - "Löfgren's syndrome was effectively treated with steroid hormones." 01/01/2003 - "Future research should disclose why the deprivation of ovarian hormones has a variable impact on women's functioning, and further trials ought to reveal effective and safe treatments for women suffering from this syndrome." 08/01/2005 - "This makes it useful in the treatment of the syndrome of resistance to thyroid hormone action, where the typical mutation affects only the beta receptor" 01/01/2007 - "AUTHORS' CONCLUSIONS: There is no evidence from controlled clinical trials that postnatal thyroid hormone treatment reduces the severity of respiratory distress syndrome, neonatal morbidity or mortality in preterm infants with respiratory distress syndrome." Get all the results and reference details, order at left...
1868 Diseases and 43760 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Tamoxifen
2.	Estrogens (Estrogen)
3.	docetaxel (Taxotere)
4.	Gonadotropin-Releasing Hormone (GnRH)
5.	Insulin (Novolin)
6.	anastrozole (Arimidex)
7.	Adrenocorticotropic Hormone (ACTH)
8.	letrozole (Femara)
9.	Aromatase Inhibitors
10.	Estramustine
3396 Drugs and Important Bio-Agents and 22570 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Castration
3.	Adjuvant Chemotherapy
4.	Ovariectomy (Oophorectomy)
5.	Combination Drug Therapy (Combination Chemotherapy)
261 Therapies and Procedures and 3028 more articles analyzed in the Research Interface, order at left...

Research Interface Subscription

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Searches
2 clicks from Disease to Drug to Evidence
Trial references
All the Positive Outcomes
Drug and Therapy searches
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>